全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Prevalence and Associated Factors of Cardiac Autonomic Neuropathy Among Diabetic Patients at Bugando Medical Centre, Mwanza, Tanzania

DOI: 10.4236/oalib.1112875, PP. 1-22

Subject Areas: Clinical Medicine, Diabetes & Endocrinology, Neurology, Cardiology, Internal Medicine

Keywords: Diabetic Cardiac Autonomic Neuropathy: Prevalence, Associated Factors, Mwanza, Tanzania

Full-Text   Cite this paper   Add to My Lib

Abstract

Introduction: DM has been implicated with multiple complications including diabetic cardiac autonomic neuropathy (DCAN), with a global burden ranging from 1% - 90% in type 1 DM and 20% - 73% in type 2 DM. Poor glycemic control, long duration of DM and traditional cardiovascular risk factors have been associated with the development and progression of DCAN. In Tanzania, there is limited data on DCAN burden and its associated factors. This study was conducted to raise awareness about DCAN, so as to establish protocols and guidelines for better diabetes management and control. Methodology: A hospital-based cross-sectional study was conducted in the DM MOPD at BMC, with a sample size of 383 DM patients. A standard questionnaire was used for Data collection, and DCAN diagnosis was made using cardiovascular autonomic reflex tests (CARTS). Data was analyzed using STATA version 15, DCAN associated factors were analyzed using bivariate logistic regression models. Results: Of 383 patients, 49.1% (188) had DCAN with heart rate variability being the most common abnormality 38.9% (149) and Postural hypotension being the least 2.4% (9). Obesity, presence of pathological Q and resting tachycardia were significantly associated with DCAN. Though statistically significant, Age, peripheral neuropathy, HbA1C, dyslipidemia, hypertension and DM duration were not analyzed in the final model because of multi-collinearity. Conclusion: DCAN is prevalent among DM patients attending MOPD at BMC. Obesity, resting tachycardia and pathological Q wave are significantly associated with DCAN. Measures should be taken to address the increase in obesity in our population. ECG should be performed in DM patients to address the grave clinical repercussion associated with pathological Q wave.

Cite this paper

Kumlin, S. S. , Kalluvya, S. E. and Mujuni, E. (2025). Prevalence and Associated Factors of Cardiac Autonomic Neuropathy Among Diabetic Patients at Bugando Medical Centre, Mwanza, Tanzania. Open Access Library Journal, 12, e2875. doi: http://dx.doi.org/10.4236/oalib.1112875.

References

[1]  Lin, X.L., Xu, Y.F., Pan, X.W., Xu, J.Y., Ding, Y., Sun, X., et al. (2020) Global, Regional, and National Burden and Trend of Di-abetes in 195 Countries and Territories: An Analysis from 1990 to 2025. Scientific Reports, 10, Article No. 14790. https://doi.org/10.1038/s41598-020-71908-9
[2]  Mercer, T., Chang, A.C., Fischer, L., Gardner, A., Kerubo, I., Tran, D.N., et al. (2019) Mitigating the Burden of Diabetes in Sub-Saharan Africa through an Integrated Diagonal Health Systems Approach. Diabetes, Metabolic Syndrome and Obesity, 12, 2261-2272. https://doi.org/10.2147/DMSO.S207427
[3]  |NCD Alliance (2025) Tanzania and Guinea Take Action against Diabetes. https://ncdalliance.org/why-ncds/video-stories-of-change /tanzania-and-guinea-take-action-against-diabetes
[4]  (1988) R.K. Consensus Statement Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy. San Anto-nio.
[5]  Khatoon, N., Santhosh Kumar, B. and Hannan Hazari, M.A. (2010) Cardiovascular Autonomic Neuropathy in Pa-tients with Diabetes Mellitus. International Journal of Pharma and Bio Sciences, 1, 17-39.
[6]  Andersen, S.T., Witte, D.R., Fleischer, J., Andersen, H., Lauritzen, T., Jørgensen, M.E., et al. (2018) Risk Factors for the Presence and Progression of Car-diovascular Autonomic Neuropathy in Type 2 Diabetes: ADDITION-Denmark. Diabetes Care, 41, 2586-2594. https://doi.org/10.2337/dc18-1411
[7]  Migisha, R., Agaba, D.C., Katamba, G., Kwaga, T., Tumwesigye, R., Miranda, S.L., et al. (2020) Prevalence and Correlates of Cardiovascular Autonomic Neuropathy among Patients with Diabetes in Uganda: A Hospital-Based Cross-Sectional Study. Global Heart, 15, 21. https://doi.org/10.5334/gh.765
[8]  Ruhangisa, F.G., Chamba, N.G., Kilonzo, K.G., Shao, E.R., Tarimo, G.A.T.C., Lyaruu, I.A., et al. (2022) Prevalence of Prolonged QTc Interval and Associated Factors among Type Two Diabetic Patients at Kilimanjaro Christian Medical Centre, in North?Eastern Tanza-nia. Journal of Diabetic Complications & Medicine, 7, 1-9. https://www.hilarispublisher.com/abstract/prevalence-of-prolonged -qtc-interval-and-associated-factors-among-type-two-diabetic-pati ents-at-kilimanjaro-christian-me-90914.html
[9]  Pacher, P., Liaudet, L., Soriano, F.G., Mabley, J.G., Szabó, E. and Szabó, C. (2002) The Role of Poly(ADP-Ribose) Polymerase Activation in the Development of Myocardial and Endothe-lial Dysfunction in Diabetes. Diabetes, 51, 514-521. https://doi.org/10.2337/diabetes.51.2.514
[10]  Obrosova, I.G. (2002) How Does Glucose Generate Oxidative Stress in Peripheral Nerve? International Review of Neurobiology, 50, 3-35. https://doi.org/10.1016/s0074-7742(02)50071-4
[11]  Sundkvist, G., Velloso, L.A., Kämpe, O., Rabinowe, S.L., Ivarsson, S.A., Lilja, B., et al. (1994) Glutamic Acid Decarboxylase Antibodies, Autonomic Nerve Antibodies and Autonomic Neuropa-thy in Diabetic Patients. Diabetologia, 37, 293-299. https://doi.org/10.1007/s001250050108
[12]  Balducci, S., Sacchetti, M., Haxhi, J., Orlando, G., D’Errico, V., Fallucca, S., et al. (2014) Physical Exercise as Therapy for Type 2 Diabetes Mellitus. Diabetes/Metabolism Research and Reviews, 30, 13-23. https://doi.org/10.1002/dmrr.2514
[13]  Tesfaye, S., Boulton, A.J.M., Dyck, P.J., Freeman, R., Horowitz, M., Kempler, P., et al. (2010) Diabetic Neuropathies: Update on Definitions, Diag-nostic Criteria, Estimation of Severity, and Treatments. Diabetes Care, 33, 2285-2293. https://doi.org/10.2337/dc10-1303
[14]  Lin, K., Wei, L.L., Huang, Z.H. and Zeng, Q. (2017) Combination of Ewing Test, Heart Rate Variability, and Heart Rate Turbulence Analysis for Early Diagnosis of Diabetic Cardiac Autonomic Neuropathy. Medicine, 96, e8296. https://doi.org/10.1097/md.0000000000008296
[15]  Kumar, S., Pathak, A., Gupta, S. and Agrawal, S. (2017) Evaluation of Cardiovascular Autonomic Nervous Functions in Diabetics: Study in A Rural Teaching Hos-pital. Journal of the Practice of Cardiovascular Sciences, 3, 150-157. https://doi.org/10.4103/jpcs.jpcs_50_17
[16]  Pan, Q., Li, Q.M., Deng, W., Zhao, D., Qi, L., Huang, W., et al. (2019) Prevalence and Diagnosis of Diabetic Cardiovascular Autonomic Neuropathy in Beijing, China: A Retrospective Multicenter Clinical Study. Frontiers in Neuroscience, 13, Article 1144. https://doi.org/10.3389/fnins.2019.01144
[17]  Gandhi Archana, U., Patel Hiren, P., Patel Sangita, V., Kadam Abhishek, Y. and Parmar Vidhi, M. (2017) Cardiac Autonomic Neuropathy in Relation to Cardiovascular Reflex Tests and QTc Prolon-gation in Diabetes Mellitus. National Journal of Integrated Research in Medicine, 8, 68-72.
[18]  Khandelwal, E., Jaryal, A.K. and Deepak, K.K. (2011) Pattern and Prevalence of Cardiovascular Autonomic Neuropathy in Diabetics Visiting a Tertiary Care Referral Center in India. Indian Journal of Physiology and Pharmacology, 55, 119-127.
[19]  Moţăţăianu, A., Maier, S., Bajko, Z., Voidazan, S., Bălaşa, R. and Stoian, A. (2018) Cardiac Autonomic Neuropathy in Type 1 and Type 2 Diabetes Pa-tients. BMC Neurology, 18, Article No. 126. https://doi.org/10.1186/s12883-018-1125-1
[20]  Zoppini, G., Cacciatori, V., Raimondo, D., Gemma, M., Trombetta, M., Dauriz, M., et al. (2015) Prevalence of Cardiovascular Autonomic Neuropathy in A Cohort of Patients with Newly Diagnosed Type 2 Diabetes: The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS). Diabetes Care, 38, 1487-1493. https://doi.org/10.2337/dc15-0081
[21]  Kempler, P., Tesfaye, S., Chaturvedi, N., Ste-vens, L.K., Webb, D.J., Eaton, S., et al. (2002) Autonomic Neuropathy Is Associated with Increased Cardiovascular Risk Fac-tors: The EURODIAB IDDM Complications Study. Diabetic Medicine, 19, 900-909. https://doi.org/10.1046/j.1464-5491.2002.00821.x
[22]  Jennifer, K. (2020) Cardiac Autonomic Neuropathy in Diabetes Mellitus: Prevalence, Associa-Tionwith Microvascular and Macrovascular Complications and Utility of Corrected QT Interval in the ECG in Predicting Diagnosis. Journal, 4, 88-100.
[23]  Dafaalla, M.D., Nimir, M.N., Mohammed, M.I., Ali, O.A. and Hussein, A. (2016) Risk Factors of Diabetic Cardiac Autonomic Neuropathy in Patients with Type 1 Diabetes Mellitus: A Me-ta-Analysis. Open Heart, 3, e000336. https://doi.org/10.1136/openhrt-2015-000336
[24]  Dhumad, M.M., Hamdan, F.B., Khudhair, M.S. and Al-Matubsi, H.Y. (2021) Correlation of Staging and Risk Factors with Cardiovascular Autonomic Neu-ropathy in Patients with Type II Diabetes Mellitus. Scientific Reports, 11, Article No. 3576. https://doi.org/10.1038/s41598-021-80962-w
[25]  Darbandi, M., Pasdar, Y., Moradi, S., Mohamed, H.J.J., Hamzeh, B. and Salimi, Y. (2020) Discriminatory Capacity of Anthropometric Indices for Cardiovascular Disease in Adults: A Systematic Review and Meta-Analysis. Preventing Chronic Disease, 17, Article 200112. https://doi.org/10.5888/pcd17.200112
[26]  Soejima, H., Ogawa, H., Morimoto, T., Okada, S., Sakuma, M., Nakayama, M., et al. (2019) One Quarter of Total Myocardial Infarctions Are Silent Manifestation in Patients with Type 2 Diabetes Mellitus. Journal of Cardiology, 73, 33-37. https://doi.org/10.1016/j.jjcc.2018.05.017
[27]  Niakan, E. (1986) Silent Myocardial Infarction and Diabetic Cardiovascular Autonomic Neuropathy. Archives of Internal Medicine, 146, 2229-2230. https://doi.org/10.1001/archinte.1986.00360230169023
[28]  Pop-Busui, R. (2010) Cardiac Autonomic Neuropathy in Diabetes. Diabetes Care, 33, 434-441. https://doi.org/10.2337/dc09-1294
[29]  Wieling, W. (1987) Heart Rate Variability in Healthy Subjects: Effect of Age and Derivation of Normal Ranges for Tests of Autonomic Function. Heart, 57, 109-110. https://doi.org/10.1136/hrt.57.1.109-a
[30]  Pappachan, J.M., Sebastian, J., Bino, B.C., Jayaprakash, K., Vijayakumar, K., Sujathan, P., et al. (2008) Cardiac Autonomic Neuropathy in Diabetes Mellitus: Prevalence, Risk Factors and Utility of Cor-rected QT Interval in the ECG for Its Diagnosis. Postgraduate Medical Journal, 84, 205-210.
[31]  Vasheghani, M., Sarvghadi, F. and Beyranvand, M.R. (2019) The Association between Cardiac Autonomic Neuropathy and Diabetes Control. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 12, 581-587. https://doi.org/10.2147/dmso.s196729
[32]  Eze, C., Onwuekwe, I. and Ogunniyi, A. (2013) The Frequency and Pattern of Cardiac Autonomic Neuropathy (CAN) in Type 2 DM Patients in A Diabetic Clinic in Enugu South-East Nigeria. Nigerian Journal of Medicine, 22, 24-31.
[33]  Poon, A.K., Whitsel, E.A., Heiss, G., Soliman, E.Z., Wagenknecht, L.E., Suzuki, T., et al. (2020) Insulin Resistance and Reduced Cardiac Autonomic Function in Older Adults: The Atherosclerosis Risk in Communi-ties Study. BMC Cardiovascular Disorders, 20, Article No. 217. https://doi.org/10.1186/s12872-020-01496-z
[34]  Bissinger, A. (2017) Cardiac Autonomic Neuropathy: Why Should Cardiologists Care about That? Journal of Diabetes Research, 2017, Article 5374176. https://doi.org/10.1155/2017/5374176
[35]  Baro, A., Bhuyan, A., Sarma, D. and Choudhury, B. (2019) A Study of Car-diac Autonomic Neuropathy in Patients with Type 2 Diabetes Mellitus: A Northeast India Experience. Indian Journal of En-docrinology and Metabolism, 23, 246-250. https://doi.org/10.4103/ijem.ijem_336_18
[36]  Witte, D.R., Tesfaye, S., Cha-turvedi, N., Eaton, S.E.M., Kempler, P. and Fuller, J.H. (2004) Risk Factors for Cardiac Autonomic Neuropathy in Type 1 Diabetes Mellitus. Diabetologia, 48, 164-171. https://doi.org/10.1007/s00125-004-1617-y
[37]  Ayad, F., Belhadj, M., Pariés, J., Attali, J.R. and Valensi, P. (2010) Association between Cardiac Autonomic Neuropathy and Hypertension and Its Potential Influence on Diabetic Complications. Diabetic Medicine, 27, 804-811. https://doi.org/10.1111/j.1464-5491.2010.03027.x
[38]  Schroeder, E.B., Liao, D., Chambless, L.E., Prineas, R.J., Evans, G.W. and Heiss, G. (2003) Hypertension, Blood Pressure, and Heart Rate Variability. The Atherosclerosis Risk in Communi-ties (ARIC) Study. Hypertension, 42, 1106-1111. https://doi.org/10.1161/01.hyp.0000100444.71069.73
[39]  Pafili, K., Trypsianis, G., Papazoglou, D., Maltezos, E. and Papanas, N. (2019) Correlation of Cardiac Autonomic Neuropathy with Small and Large Peripheral Nerve Function in Type 2 Diabetes Mellitus. Diabetes Research and Clinical Practice, 156, Arti-cle 107844. https://doi.org/10.1016/j.diabres.2019.107844
[40]  Tentolouris, N., Pagoni, S., Tzonou, A. and Katsilambros, N. (2001) Peripheral Neuropathy Does Not Invariably Coexist with Autonomic Neuropathy in Diabetes Melli-tus. European Journal of Internal Medicine, 12, 20-27. https://doi.org/10.1016/s0953-6205(00)00128-x
[41]  Vincent, A.M., Russell, J.W., Low, P. and Feldman, E.L. (2004) Oxidative Stress in the Pathogenesis of Diabetic Neuropathy. Endo-crine Reviews, 25, 612-628. https://doi.org/10.1210/er.2003-0019
[42]  Song, L., Zhou, L. and Tang, Z. (2016) An Asso-ciation Analysis of Lipid Profile and Diabetic Cardiovascular Autonomic Neuropathy in A Chinese Sample. Lipids in Health and Disease, 15, Article No. 122. https://doi.org/10.1186/s12944-016-0287-3
[43]  Ukpabi, O.J. and Onwubere, B.J. (2018) QTc Prolongation in Black Diabetic Subjects with Cardiac Autonomic Neuropathy. African Health Sciences, 17, 1092-1100. https://doi.org/10.4314/ahs.v17i4.17

Full-Text


Contact Us

[email protected]

QQ:3279437679

WhatsApp +8615387084133